|
Antiplatelets
Citations 221-230 of 262 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke. Data From the European BIOMED Stroke Project
- Salah-Eddine Megherbi, Chantal Milan, Dominique Minier, Grégory Couvreur, Guy-Victor Osseby, Kate Tilling, Antonio Di Carlo, Domenico Inzitari, Charles D.A. Wolfe, Thibault Moreau, Maurice Giroud, and for the European BIOMED Study of Stroke Care Group
Stroke published February 6, 2003, doi:10.1161/01.STR.0000057975.15221.40
[Abstract]
- Articles
Dipyridamole Enhances NO/cGMP-Mediated Vasodilator-Stimulated Phosphoprotein Phosphorylation and Signaling in Human Platelets. In Vitro and In Vivo/Ex Vivo Studies
- Barsom Aktas, Andrea Utz, Petra Hoenig-Liedl, Ulrich Walter, and Joerg Geiger
Stroke published January 30, 2003, doi:10.1161/01.STR.0000056527.34434.59
[Abstract]
- Comments, Opinions, and Reviews
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials
- Robert G. Hart, Santiago Palacio, and Lesly A. Pearce
Stroke 2002;33:2722-2727, doi:10.1161/01.STR.0000035735.49388.4A
[Abstract]
[Full text]
- Short Communications
Intracerebral Hemorrhages Associated With Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
- Adnan I. Qureshi, Mustafa Saad, Osama O. Zaidat, Jose I. Suarez, Michael J. Alexander, M. Fareed, K. Suri, Zulfiqar Ali, and L. Nelson Hopkins
Stroke 2002;33:1916-1919, doi:10.1161/01.STR.0000019423.08947.43
[Abstract]
[Full text]
- Emerging Therapies
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial: Is Warfarin Really a Reasonable Therapeutic Alternative to Aspirin for Preventing Recurrent Noncardioembolic Ischemic Stroke?
- Graeme J. Hankey
Stroke 2002;33:1723-1726, doi:10.1161/01.STR.0000016922.22707.27
[Full text]
- Case Reports
Acute Basilar Artery Occlusion Treated With Combined Intravenous Abciximab and Intra-arterial Tissue Plasminogen Activator: Report of 3 Cases
- Bernd Eckert, Christoph Koch, Götz Thomalla, Joachim Roether, and Herrmann Zeumer
Stroke 2002;33:1424-1427, doi:10.1161/01.STR.0000014247.70674.7F
[Abstract]
[Full text]
- Original Contributions
Stroke Risk Factor Profiles in African American Women: An Interim Report From the African-American Antiplatelet Stroke Prevention Study
- Bradford B. Worrall, Karen C. Johnston, Gail Kongable, Elena Hung, DeJuran Richardson, and Philip B. Gorelick
Stroke 2002;33:913-919, doi:10.1161/hs0402.105337
[Abstract]
[Full text]
- Original Contributions
Abciximab Bolus Injection Does Not Reduce Cerebral Ischemic Complications of Elective Carotid Artery Stenting: A Randomized Study
- Robert Hofmann, Klaus Kerschner, Clemens Steinwender, Alexander Kypta, Dietmar Bibl, and Franz Leisch
Stroke 2002;33:725-727, doi:10.1161/hs0302.104545
[Abstract]
[Full text]
- Original Contributions
Aspirin and Urinary 11-Dehydrothromboxane B2 in African American Stroke Patients
- Askiel Bruno, Joseph P. McConnell, Harry H. Mansbach, III, Stanley N. Cohen, Gretchen E. Tietjen, and Nils U. Bang
Stroke 2002;33:57-60, doi:10.1161/hs0102.102010
[Abstract]
[Full text]
- Original Contributions
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients With Atrial Fibrillation?
- Andrew Evans, Iñigo Perez, Gloria Yu, and Lalit Kalra
Stroke 2001;32:2828-2832, doi:10.1161/hs1201.099520
[Abstract]
[Full text]
|
|
